Top

Published in:

01-04-2012 | Case Report

Successful hepatectomy for intraperitoneal rupture of pyogenic liver abscess caused by Klebsiella pneumoniae

Authors: Kazuhiko Morii, Asako Kashihara, Sho Miura, Hiroaki Okuhin, Takanori Watanabe, Shiso Sato, Koichi Uesaka, Shiro Yuasa

Published in: Clinical Journal of Gastroenterology | Issue 2/2012

Abstract

Klebsiella pneumoniae (KP) is the most common cause of pyogenic liver abscess in eastern Asia. KP liver abscess commonly presents as a single large abscess with a predominantly solid consistency. It is sometimes unsuitable for percutaneous catheter drainage because of the poorly liquefied contents. Antibiotic therapy alone may raise a probability of treatment failure and occurrence of complications such as abscess rupture. Hepatic or portal venous thrombosis, hematogenous spread, and spontaneous rupture also occur frequently. We report a case of KP liver abscess with a typical solid appearance, complicated by disseminated intravascular coagulation, spontaneous rupture, and pyogenic spondylitis.

Chang FY, Chou MY. Comparison of pyogenic liver abscesses caused by Klebsiella pneumoniae and non-K. pneumoniae pathogens. J Formos Med Assoc. 1995;95:232–7.

Okano H, Shiraki K, Inoue H, Kawakita T, Yamamoto N, Deguchi M, Sugimoto K, Sasaki T, Ohmori S, Murata K, Nakano T. Clinicopathological analysis of liver abscess in Japan. Int J Mol Med. 2002;10:627–30.PubMed

Lederman ER, Crum NF. Pyogenic liver abscess with a focus on Klebsiella pneumonia as a primary pathogen: an emerging disease with unique clinical characteristics. Am J Gastroenterol. 2005;100:322–31.PubMedCrossRef

Wang JH, Liu YC, Lee SS, Yen MY, Chen YS, Wang JH, Wann SR, Lin HH. Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis. 1998;26:1434–8.PubMedCrossRef

Alsaif HS, Venkatesh SK, Chan DSG, Archuleta A. CT appearance of pyogenic liver abscesses caused by Klebsiella pneumoniae. Radiology. 2011;260:129–38.PubMedCrossRef

Kim SB, Je BK, Lee KY, Lee SH, Chung HH, Cha SH. Computed tomographic differences of pyogenic liver abscesses caused by Klebsiella pneumoniae and non-Klebsiella pneumoniae. J Comput Assist Tomogr. 2007;31:59–65.PubMedCrossRef

Cheng DL, Liu YC, Yen MY. Pyogenic liver abscess: clinical manifestations and value of percutaneous catheter drainage treatment. J Formos Med Assoc. 1990;89:571–6.PubMed

Cheng DL, Liu YC, Yen MY, Liu CY, Wang RS. Septic metastatic lesions of pyogenic liver abscess. Their association with Klebsiella pneumoniae bacteremia in diabetic patients. Arch Intern Med. 1991;151:1557–9.PubMedCrossRef

Lee KH, Han JK, Kim YJ, Lee HJ, Park SH, Choi BI. Hepatic attenuation differences associated with obstruction of the portal or hepatic veins in patients with hepatic abscess. Am J Roentgenol. 2005;185:1015–23.CrossRef

10.

Brown KT, Gandhi RT, Covey AM, Brody LA, Getrajdman GI. Pylephlebitis and liver abscess mimicking hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2003;2:221–5.PubMed

11.

Syed MA, Kim TK, Jang HJ. Portal and hepatic vein thrombosis in liver abscess: CT findings. Eur J Radiol. 2007;61:513–9.PubMedCrossRef

12.

Chou FF, Sheen CSM, Lee TY. Rupture of pyogenic liver abscess. Am J Gastroenterol. 1995;90:767–70.PubMed

13.

Lee KT, Sheen PC, Chen JS, Ker CG. Pyogenic liver abscess: multivariate analysis of risk factors. World J Surg. 1991;15:372–7.PubMedCrossRef

14.

Lee CH, Leu HS, Wu TS, Su LH, Liu JW. Risk factor for spontaneous rupture of liver abscess caused by Klebsiella pneumoniae. Diagn Micro Infect Dis. 2005;52:79–84.CrossRef

15.

Hui JYH, Yang MKW, Cho DHY, Li T, Loke TKL, Chan JCS, Woo PCY. Pyogenic liver abscesses caused by Klebsiella pneumoniae: US appearance and aspiration findings. Radiology. 2007;242:769–76.PubMedCrossRef

16.

Lee NK, Kim S, Lee JW, Jeong YJ, Lee SH, Heo J, Kang DH. CT differentiation of pyogenic liver abscesses caused by Klebsiella pneumoniae vs non-Klebsiella pneumoniae. Br J Radiol. 2011;54:518–25.CrossRef

17.

Lublin M, Bartlett DL, Danforth DN, Kauffman H, Gallin GI, Malech HL, Shawker T, Choyke P, Kleiner DE, Schwartzentruber DJ, Chang R, DeCarlo ES, Holland SM. Hepatic abscess in patients with chronic granulomatous disease. Ann Surg. 2002;235:383–91.PubMedCrossRef

18.

Stephan F, Hollande J, Richard O, et al. Thrombocytopenia in a surgical ICU. Chest. 1999;115:1363–70.PubMedCrossRef

19.

Schiffer CA, Anderson KC, Benett CL, et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the American society of clinical oncology. J Clin Oncol. 2001;19:1519–38.PubMed

20.

O’Shaughnessy DF, Atterbury C, Maggs PB, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol. 2004;126:11–28.PubMedCrossRef

21.

Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434–40.PubMedCrossRef

22.

Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–2.PubMedCrossRef

23.

Torzilli G, Minagawa M, Takayama T, et al. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy. Hepatology. 1999;30:889–93.PubMedCrossRef

24.

Ishizawa T, Hasegawa K, Aoki T, et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology. 2008;134:1908–16.PubMedCrossRef

Title: Successful hepatectomy for intraperitoneal rupture of pyogenic liver abscess caused by Klebsiella pneumoniae
Authors: Kazuhiko Morii
Asako Kashihara
Sho Miura
Hiroaki Okuhin
Takanori Watanabe
Shiso Sato
Koichi Uesaka
Shiro Yuasa
Publication date: 01-04-2012
Publisher: Springer Japan
Published in: Clinical Journal of Gastroenterology / Issue 2/2012
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI: https://doi.org/10.1007/s12328-012-0293-6

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2012

Efficient palliative involved-field radiotherapy on highly progressive diffuse large B-cell primary gastric lymphoma with liver cirrhosis

Elevation of carcinoembryonic antigen coinciding with disease activity of ulcerative colitis

Recent progress in endoscopic ultrasonography guided biliary intervention

Gastric variceal bleeding caused by an intrahepatic arterioportal fistula that formed after liver biopsy: a case report and review of the literature

Eosinophilic gastroenteritis in a patient with chronic hepatitis C who received treatment with pegylated interferon

Development of a hepatocellular carcinoma in a chronic hepatitis C patient 18 years after achieving a sustained virological response to interferon therapy: case report and literature review

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials